Bios Equity COF, LP insider trades
Bios Equity COF, LP has filed 1 Form 4 with the SEC that we hold, all for Actuate Therapeutics, INC. (ACTU), as Director, 10% owner. Across all of them we count 1 purchase worth $500.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 71,428 shares of Actuate Therapeutics, INC. worth $500.0K, dated 2025-06-27. The first filing on our record is dated 2025-06-30 and the latest 2025-06-30.
Actuate Therapeutics, INC. (ACTU)
Director, 10% owner · 1 filing · 1 purchase or sale
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2025-06-27 | P, purchase reported on Form 4 | 71,428 | $500.0K | 2025-06-30 | SEC |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 2000747) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
